Cargando…

Clinical study of Shengxuening tablet combined with rHuEPO for the treatment of renal anemia of maintenance hemodialysis patients

The aim of the present study was to investigate the clinical effects of Shengxuening tablet (silkworm excrement) combined with recombinant human erythropoietin (rHuEPO) for the treatment of renal anemia of maintenance hemodialysis (MHD) patients. Seventy-two MHD patients with renal anemia were inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	CHENG, XIN, YU, GUOJUN, HU, JIANGPING, XU, XUEFENG, LUO, FANG, SHEN, PING, ZHANG, GUOSHENG, YANG, NING
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906941/ https://www.ncbi.nlm.nih.gov/pubmed/27347032 http://dx.doi.org/10.3892/etm.2016.3307

Ejemplares similares

rHuEPO Hyporesponsiveness and Related High Dosages Are Associated with Hyperviscosity in Maintenance Hemodialysis Patients
por: Erkmen Uyar, Mehtap, et al.
Publicado: (2013)

Darbepoetin alfa is more potent in vivo and can be administered less frequently than rHuEPO
por: Egrie, J, et al.
Publicado: (2002)

A Conjugated Aptamer-Gold Nanoparticle Fluorescent Probe for Highly Sensitive Detection of rHuEPO-α
por: Sun, Jiefang, et al.
Publicado: (2011)

Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration
por: Wang, Guan, et al.
Publicado: (2017)

Proof-of-concept study on improved efficacy of rHuEPO administered as a long-term infusion in rats
por: Szczesny, Damian, et al.
Publicado: (2020)

Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment
por: Kittur, Farooqahmed S., et al.
Publicado: (2023)

The efficiency and safety of Shengxuening tablet on treating and preventing iron deficiency anemia: A systematic review and meta-analysis
por: Zhang, Yanyu, et al.
Publicado: (2022)

Shengxuening versus Oral Iron Supplementation for the Treatment of Renal Anemia: A Systematic Review
por: Zeng, Qin, et al.
Publicado: (2020)

r.hu-Erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline
por: Tapolyai, Mihály, et al.
Publicado: (2003)

Receptor-mediated mitophagy regulates EPO production and protects against renal anemia
por: Geng, Guangfeng, et al.
Publicado: (2021)

Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
por: Rauner, Martina, et al.
Publicado: (2021)

Regulation of Hepcidin-25 by Short- and Long-Acting rhEPO May Be Dependent on Ferritin and Predict the Response to rhEPO in Hemodialysis Patients
por: Takasawa, Kazuya, et al.
Publicado: (2014)

The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia
por: Landau, Daniel, et al.
Publicado: (2018)

A Telemedicine-Based Registration System for the Management of Renal Anemia in Patients on Maintenance Hemodialysis: Multicenter Study
por: Ni, Zhaohui, et al.
Publicado: (2019)

Artificial intelligence supported anemia control system (AISACS) to prevent anemia in maintenance hemodialysis patients
por: Ohara, Toshiaki, et al.
Publicado: (2021)

Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis
por: Vočanec, Danijela, et al.
Publicado: (2018)

Correct anemia or prevent acute myocardial infarction in patients on maintenance hemodialysis?
por: Zhao, Yu, et al.
Publicado: (2019)

EPOS Abstract Book
Publicado: (2022)

Welcome to EPOS 2023
por: Sanpera, Ignacio, et al.
Publicado: (2023)

EPOS Abstract Book
Publicado: (2023)

The Effects of Curcumae Longae Radix, Curcuma phaeocaulis Radix and Their Processed Products on Epo/EpoR Pathway and CD62p
por: Chen, Zhimin, et al.
Publicado: (2018)

Local YB-1, Epo, and EpoR concentrations in fractured bones: results from a porcine model of multiple trauma
por: Bläsius, Felix Marius, et al.
Publicado: (2023)

The RNA-binding protein HuR is required for maintenance of the germinal centre response
por: Osma-Garcia, Ines C., et al.
Publicado: (2021)

Roxadustat treatment for erythropoiesis-stimulating agent-hyporesponsive anemia in maintenance hemodialysis patients
por: Song, Jie, et al.
Publicado: (2023)

Reduced nuclear export of HuR mRNA by HuR is linked to the loss of HuR in replicative senescence
por: Yi, Jie, et al.
Publicado: (2010)

Optimal EPO dosing in hemodialysis patients using a non-linear model predictive control approach
por: Rogg, S., et al.
Publicado: (2019)

The therapeutic role of Jingchuan tablet on ischaemic cerebral stroke via the HIF-1α/EPO/VEGFA signalling pathway
por: Zhang, Yan, et al.
Publicado: (2022)

How to pursue EPO in MS
por: Bartels, Claudia, et al.
Publicado: (2017)

HuB and HuD repress telomerase activity by dissociating HuR from TERC
por: Cheng, Xiaolei, et al.
Publicado: (2021)

UHPLC-ESI-MS/MS Quantitative Analyses of Multicomponent Hu Gan Tablets
por: Liang, Jun, et al.
Publicado: (2019)

Successful treatment of anti-EPO antibody associated refractory anemia with hypoxia-inducible factor prolyl hydroxylase inhibitor
por: Zhang, Huifang, et al.
Publicado: (2020)

Reduced EPO receptor expression may contribute to limited pleiotropic effects of EPO during critical illness
por: McCook, O, et al.
Publicado: (2012)

Low-Dose Maintenance Intravenous Iron Therapy Can Prevent Anemia in Children with End-Stage Renal Disease Undergoing Chronic Hemodialysis
por: Ambarsari, Cahyani Gita, et al.
Publicado: (2020)

Effect of traditional Chinese medicine Bailing capsule on renal anemia in maintenance hemodialysis patients: A protocol for systematic review and meta-analysis
por: Li, Yan-Lin, et al.
Publicado: (2022)

Hu Antigen R (HuR) Protein Structure, Function and Regulation in Hepatobiliary Tumors
por: Lachiondo-Ortega, Sofia, et al.
Publicado: (2022)

An evaluation of the EPOS selective chemistry analyser
por: Hughes, G. J., et al.
Publicado: (1987)

Erythropoietin (EPO) in acute kidney injury
por: Moore, Elizabeth, et al.
Publicado: (2011)

EPO pre-treatment for haemorrhagic shock
Publicado: (2013)

EPOS 33rd Annual Meeting
Publicado: (2014)

EPOS 33rd Annual Meeting
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8htp26vee86497706rr9bired5